June 20, 2014
First generics of Novartis Pharma’s blood pressure drug Diovan (valsartan) and authorized generics (AGs) of Takeda Pharmaceutical’s Blopress (candesartan), another blockbuster hypertension medicine, joined the NHI price list on June 20. The Ministry of Health, Labor and Welfare announced in...read more